Temporomandibular Joint (TMJ) Syndrome

Back

Practice Essentials

The temporal mandibular joint (TMJ) is a synovial hinge joint that connects the jaw to the skull. These two joints are located just in front of each ear. Each joint is composed of the condyle of the mandible, an articulating disk, and the articular tubercle of the temporal bone. The movements allowed are side to side, up and down, as well as protrusion and retrusion. This complicated joint, along with its attached muscles, allows the movements needed for speaking, chewing, and making facial expressions.[1]

Pain and functional disturbances related to the TMJ are common, and are collectively termed TMJ syndrome or temporomandibular disorders (TMD).[2, 3]  An international group has identified 12 of the most common pain-related and intra-articular TMJ disorders, which include myalgias, myofascial pain, arthralgia, disk displacement disorders, degenerative joint disease, and subluxation (see DDx/Diagnostic Considerations).

Signs and symptoms

Symptoms of TMJ syndrome consist of the following:

Characteristic findings on physical examination include the following:

See Presentation and DDx/Diagnostic Considerations for more detail.

Workup

Along with clinical examination, imaging studies are valuable for identifying causes of TMJ disorders and determining their severity. Imaging techniques used in this setting include the following[4] :

See Workup for more detail.

Treatment

Signs and symptoms of TMJ disorders tend to improve over time with or without treatment for most patients. Initial management of TMJ disorders is with a conservative multimodal approach.  A number of therapies are in use, although data supporting their efficacy is often mixed or weak and at best moderate, and reviews and guidelines offer contradictory recommendations on some therapies.[6, 7, 8] More invasive options can be considered when conservative measures have been exhausted.

See Treatment and Medication for more detail.

See also Temporomandibular Disorders.

Pathophysiology

The pathophysiology of TMJ syndrome is not entirely understood. The etiology is thought to be likely multifactorial, with contributing factors including the following[7] :

Both local insults and systemic disorders may be involved. Local problems frequently arise from articular disc displacement and hereditary conditions affecting the structures of the joint itself, such as hypoplastic mandibular condyles. A study by Tallents et al found TMJ displacement in 84% of patients with symptomatic TMJ versus 33% of asymptomatic subjects.[9]

The TMJs can also be affected by conditions such as rheumatoid arthritis, juvenile idiopathic arthritis,[10]  osteoarthritis, and diseases of the articular disks. In addition, hypermobile TMJs, nocturnal jaw clenching, nocturnal bruxism, jaw clenching due to psychosocial stresses, and local trauma also play a significant role.

A study of 299 females aged 18-60 years suggests that compared with nonsmokers, female smokers younger than 30 years had a higher risk of temporomandibular disorder than older adults.[11]

As described by Hegde, a strong understanding of how the trigeminal nerve innervates the TMJ and surrounding structures explains the pain and referred pain patterns of TMJ disorders.[12] Irritation of the mandibular branch (V3) of the trigeminal nerve results in pain locally at the TMJ and also to other areas of V3 sensory innervation, which include the ipsilateral skin, teeth, side of the head, and scalp.

Epidemiology

Frequency

United States

Currently, an estimated 10 million people have TMJ disorders, and roughly 25% of the population have symptoms at some point in their lives.

Mortality/Morbidity

The morbidity of the disorder is related to significant pain on movement of the jaw. While some patients' symptoms may resolve within weeks, others may have chronic symptoms that persist even with extensive therapy.

One study by Rammelsberg et al followed 235 patients over 5 years.[13] In this study, roughly one third of patients had complete resolution of pain, one third had continuous pain over the 5 years, and one third had recurrent episodes with periods of remission.

Race-, Sex-, and Age-related Demographics

See the list below:

Prognosis

See the list below:

Patient Education

Patient education measures may include the following:

History

Symptoms of temporomandibular joint (TMJ) syndrome may consist of the following:

Physical

Characteristic findings on physical examination include the following:

Approach Considerations

When temporomandibular joint (TMJ) syndrome is suspected, the following histories should be obtained:

Oftentimes if one of the above aggravating factors is identified, treating the underlying cause or modifying the underlying behavior may improve symptoms sufficiently that additional workup may not be needed.

Laboratory Studies

No laboratory studies are specifically indicated to rule in temporomandibular joint (TMJ) syndrome; however, appropriate laboratory samples may be drawn to help rule out other disorders if an underlying cause is not readily apparent:

Imaging Studies

Along with clinical examination, imaging studies are valuable for identifying causes of TMJ disorders and determining their severity (see DDx/Diagnostic Considerations). Imaging techniques used in this setting include the following:

The American Academy of Oral and Maxillofacial Radiology (AAOMR) and the American Academy of Orofacial Pain (AAOP) have published a position statement on TMJ imaging.[4] Recommendations are as follows: 

MRI for evaluation of TMJ disk displacement or pathology often involves central sagittal scans alone. However, Litko-Rola et al found that multisection evaluation with both sagittal and coronal scans had significantly higher sensitivity for evaluation of TMJ internal derangement. In their study of 382 TMJs in 191 patients with disk displacement, normal disk position was identified in 148 TMJs (38.7%) on central oblique sagittal scans, compared with 89 TMJs (23.3%) on all oblique sagittal and coronal scans (P< 0.001).[16]

Diagnostic Nerve Block

The auriculotemporal branch of the trigeminal nerve provides the sensory innervation of the TMJ. A diagnostic nerve block of the auriculotemporal nerve can be helpful in differentiating whether unilateral orofacial pain originates in the TMJ capsule.[17]

To perform a diagnostic anesthesia block, use a 25- to 30-gauge needle and inject 0.5 mL of short-acting anesthetic about 0.5 inches below the skin just inferior and lateral to the mandibular condyle. If the patient does not experience pain relief with the nerve block, consider other causes of the orofacial pain.

Approach Considerations

In most patients, the signs and symptoms of temporomandibular joint (TMJ) disorders improve over time with or without treatment. As many as 50% of patients have symptomatic improvement in 1 year and 85% in 3 years.[7]

Initial management of TMJ disorders is with a conservative multimodal approach.[6]  A number of therapies are in use, although data supporting their efficacy is often mixed or weak and at best moderate, and reviews and guidelines offer contradictory recommendations on some therapies.[6, 7, 8]  More-invasive options can be considered when conservative measures have been exhausted.

Medical Care

Conservative treatment of TMJ syndrome may include the following[7, 18, 19] :

Pharmacologic therapy

Pharmacologic therapy for acute and chronic TMJ-related pain includes acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs).[29]   Topical NSAIDs such as diclofenac can be used to minimize risk of adverse effects seen more commonly with oral formulations. For muscular spasms and teeth-clenching, agents such as muscle relaxers or even benzodiazepines may be used. Tricyclic antidepressants (TCAs) are second-line options for pain and teeth grinding. Note that selective serotonin uptake inhibitors (SSRIs) may induce bruxism.[7]

Injections

If conservative therapies fail, or for severe acute exacerbations, intra-articular injection of local anesthetics or steroids may be used for TMJ syndrome. However, repeated intra-articular injections are not recommended.

Intramuscular injection of onabotulinumtoxinA (BTX-A) has been advocated for management of myofascial pain. A systematic review of BTX-A injections for myofascial pain related to TMJ disorders found that it was significantly effective in reducing the intensity of pain, although a few studies have reported that BTX-A and saline placebo injections had statistically equivalent ability to decrease pain and improve jaw function.[30, 31]

TMJ syndrome in juvenile idiopathic arthritis

A guideline from the American College of Rheumatology includes recommendations for the treatment of active TMJ arthritis in patients with juvenile idiopathic arthritis.[32] All but one of the recommendations are conditional, and all involve very low certainty of evidence. The recommendations are as follows:

Inflammatory arthritis due to conditions such as rheumatoid arthritis may rarely affect the TMJ, often in a bilateral manner, given the predilection for diseases such as rheumatoid arthritis to affect joints in a fairly symmetric pattern. Timely disease control is of vital importance when TMJ pain is thought to be due to inflammatory arthritis, as the feared result of undertreating is permanent damage to the joint, often leading to a secondary osteoarthritis of the joint, which portends a much more chronic refractory disease process.

Surgical Care

If conservative treatments fail, operative repair may be considered.[33] Operative repair can range from arthroscopic procedures, which can wash out the joint and allow for small repairs,[34] to open procedures. Open procedures can utilize jaw implants, synthetic articular disks, or total TMJ replacement with custom-made alloplastic prostheses.[35] With TMJ ankylosis associated with juvenile idiopathic arthritis, reconstruction with a costochondral graft is the gold standard.[36]

However, in a long-term study by Fricton et al, synthetic implants did not lead to an improved outcome compared with nonimplant surgical repair or nonsurgical rehabilitation.[37] This was determined by looking at subjective and objective measures of symptom severity and functional deficits.

Handa et al reported on a complication of TMJ surgery termed first bite syndrome, in which pain (most often in the parotid region) is triggered by a taste stimulus and subsides with subsequent bites of food. In 19 patients who had undergone TMJ surgery, the median duration of onset was 2.75 months postoperatively. The syndrome resolved spontaneously in two patients and resolved completely with onabotulinum toxin A injections in one patient.[38]

Consultations

Offer routine follow-up care with an ear, nose, and throat (ENT) specialist, dentist, or an oral maxillofacial surgeon (OMFS). If intractable pain and/or dislocation are present, more urgent consultation may be necessary.

Medication Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) and tricyclic antidepressants (TCAs) are the mainstays of pharmacologic treatment for temporomandibular joint (TMJ) syndrome. Patients with protracted pain syndromes eventually may require muscle relaxants or intra-articular corticosteroid injections. In refractory cases, benzodiazepines or opiates may be considered but should be avoided if possible.

Ibuprofen (Motrin, Advil, Ibuprin, Nuprin)

Clinical Context:  Recommended dosing is 400 to 800 mg two or three times a day for 10 to 14 days.

Naproxen (Aleve, Anaprox, Naprosyn)

Clinical Context:  Recommended dosing is 250 to 500 mg twice daily for 10 to 14 days.

Diclofenac topical

Clinical Context:  Recommended dosing is application up to four times a day for 10 to 14 days.

Celecoxib (Celebrex)

Clinical Context:  Recommended dosing is 100 or 200 mg once a day for 10 to 14 days.

Class Summary

NSAIDs are most commonly used for relief of mild to moderate pain, with use most often limited by pre-existing cardiovascular, renal, or gastrointenstinal morbidity, or concern for such morbidity. To reduce risk of adverse effects, generally the optimal approach is to use the lowest effective dose for the shortest duration possible. If more long-term use is required, the prescriber should monitor cardiovascular, renal, and gastrointestinal systems for signs of adverse effects.

Cyclobenzaprine (Amrix, Fexmid, Flexeril)

Clinical Context: 

Nortriptyline (Aventyl, Pamelor)

Clinical Context: 

Diazepam (Valium)

Clinical Context:  Use with extreme caution, given the risk of central nervous system (CNS) depression, especially in elderly patients and those already on other CNS-depressing medications.

What is temporomandibular joint (TMJ) syndrome?What causes pain in TMJ syndrome?What is the pathophysiology of TMJ syndrome?How prevalent is TMJ syndrome?What is the morbidity of TMJ syndrome?What are the demographics of TMJ syndrome?What are the symptoms of TMJ syndrome?What are the characteristic findings on physical exam in TMJ syndrome?What are the differential diagnoses for Temporomandibular Joint (TMJ) Syndrome?Which lab studies are indicated in the workup of TMJ syndrome?Which imaging studies are indicated in the workup of TMJ syndrome?What is the role of a diagnostic nerve block in the workup of TMJ syndrome?What is the initial treatment of TMJ syndrome?Which specialist consultations are indicated in the treatment of TMJ syndrome?Which medications are used in the treatment of TMJ syndrome?Which medications in the drug class Skeletal Muscle Relaxants are used in the treatment of Temporomandibular Joint (TMJ) Syndrome?Which medications in the drug class Nonsteroidal anti-inflammatory drugs (NSAIDs) are used in the treatment of Temporomandibular Joint (TMJ) Syndrome?

Author

Evan Dombrosky, MD, Rheumatologist, Central Virginia VA Health System

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Gino A Farina, MD, FACEP, FAAEM, Professor of Emergency Medicine, Hofstra North Shore-LIJ School of Medicine at Hofstra University; Program Director, Department of Emergency Medicine, Long Island Jewish Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD, Visiting Professor of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Disclosure: Nothing to disclose.

Additional Contributors

Richard H Sinert, DO, Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Disclosure: Nothing to disclose.

Steven M Heffer, MD, Consulting Staff, Department of Emergency Medicine, Greenwich Hospital

Disclosure: Nothing to disclose.

Vivian Tsai, MD, MPH, FACEP, Assistant Professor of Emergency Medicine, Mount Sinai School of Medicine, Queens Hospital Center

Disclosure: Nothing to disclose.

Acknowledgements

Jerome FX Naradzay, MD, FACEP Medical Director, Consulting Staff, Department of Emergency Medicine, Maria Parham Hospital; Medical Examiner, Vance County, North Carolina

Jerome FX Naradzay, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Joshua Parnes, MD Resident Physician, Department of Emergency Medicine, Kings County Hospital Center

Disclosure: Nothing to disclose.

References

  1. Maini K, Dua A. Temporomandibular Syndrome. 2024 Jan. [View Abstract]
  2. Palmer J, Durham J. Temporomandibular disorders. BJA Educ. 2021 Feb. 21 (2):44-50. [View Abstract]
  3. Bond EC, Mackey S, English R, et al. Temporomandibular Disorders: Priorities for Research and Care. 2020 Mar 12. [View Abstract]
  4. [Guideline] Mallya SM, Ahmad M, Cohen JR, Kaspo G, Ramesh A. Recommendations for Imaging of the Temporomandibular Joint. Position Statement from the American Academy of Oral and Maxillofacial Radiology and the American Academy of Orofacial Pain. J Oral Facial Pain Headache. 2023 Winter. 37 (1):7-15. [View Abstract]
  5. Dental Cone-beam Computed Tomography. U.S. Food & Drug Administration. Available at https://www.fda.gov/radiation-emitting-products/medical-x-ray-imaging/dental-cone-beam-computed-tomography. September 28, 2020; Accessed: March 18, 2024.
  6. Tran C, Ghahreman K, Huppa C, Gallagher JE. Management of temporomandibular disorders: a rapid review of systematic reviews and guidelines. Int J Oral Maxillofac Surg. 2022 Sep. 51 (9):1211-1225. [View Abstract]
  7. Wadhokar OC, Patil DS. Current Trends in the Management of Temporomandibular Joint Dysfunction: A Review. Cureus. 2022 Sep. 14 (9):e29314. [View Abstract]
  8. Koca CG, Yildirim B, Bilgir E. Effects of bruxism on temporomandibular joint internal derangement in patients with unilateral temporomandibular joint pain: The role of magnetic resonance imaging diagnostics. Cranio. 2024 Mar. 42 (2):113-121. [View Abstract]
  9. Tallents, RH, Katzberg, RW, Murphy W, Proskin, et al. Magnetic resonance imaging findings in asymptomatic volunteers and symptomatic patients with temporomandibular disorders. J Prosthet Dent. 1996. 75:529. [View Abstract]
  10. Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, et al. Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2017 May. 69 (5):677-686. [View Abstract]
  11. Sanders AE, Maixner W, Nackley AG, Diatchenko L, By K, Miller VE, et al. Excess risk of temporomandibular disorder associated with cigarette smoking in young adults. J Pain. 2012 Jan. 13(1):21-31. [View Abstract]
  12. Hegde V. A review of the disorders of the temporomandibular joint. J Indian Prosthodont Soc. 2005. 5:56-61.
  13. Rammelsberg P, LeResche L, Dworkin S. Longitudinal outcome of temporomandibular disorders: a 5-year epidemiologic study of muscle disorders defined by research diagnostic criteria for temporomandibular disorders. J Orofac Pain. 2003. 17(1):9-20. [View Abstract]
  14. Schiffman E, et al; International RDC/TMD Consortium Network, International association for Dental Research, Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache. 2014 Winter. 28 (1):6-27. [View Abstract]
  15. Ahn SJ, Kim TW, Lee DY. Evaluation of internal derangement of the temporomandibular joint by panoramic radiographs compared with magnetic resonance imaging. Am J Orthod Dentofacial Orthop. 2006 Apr. 129(4):479-85. [View Abstract]
  16. Litko-Rola M, Szkutnik J, Różyło-Kalinowska I. The importance of multisection sagittal and coronal magnetic resonance imaging evaluation in the assessment of temporomandibular joint disc position. Clin Oral Investig. 2021 Jan. 25 (1):159-168. [View Abstract]
  17. American Academy of Family Physicians. Temporomandibular join (TMJ) pain. Am Fm Physician. 2007 Nov. 76(10):1483-4. [View Abstract]
  18. [Guideline] Busse JW, Casassus R, Carrasco-Labra A, Durham J, Mock D, Zakrzewska JM, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15. 383:e076227. [View Abstract]
  19. Ferrillo M, Giudice A, Marotta N, Fortunato F, Di Venere D, Ammendolia A, et al. Pain Management and Rehabilitation for Central Sensitization in Temporomandibular Disorders: A Comprehensive Review. Int J Mol Sci. 2022 Oct 12. 23 (20):[View Abstract]
  20. La Touche R, Martínez García S, Serrano García B, Proy Acosta A, Adraos Juárez D, Fernández Pérez JJ, et al. Effect of Manual Therapy and Therapeutic Exercise Applied to the Cervical Region on Pain and Pressure Pain Sensitivity in Patients with Temporomandibular Disorders: A Systematic Review and Meta-analysis. Pain Med. 2020 Mar 17. [View Abstract]
  21. Al-Moraissi EA, Farea R, Qasem KA, Al-Wadeai MS, Al-Sabahi ME, Al-Iryani GM. Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2020 Jan 22. [View Abstract]
  22. Riley P, Glenny AM, Worthington HV, Jacobsen E, Robertson C, Durham J, et al. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation. Health Technol Assess. 2020 Feb. 24 (7):1-224. [View Abstract]
  23. Zayan K, Felix ER, Galor A. Transcutaneous Electrical Nerve Stimulation for Facial Pain. Prog Neurol Surg. 2020. 35:35-44. [View Abstract]
  24. Venezian GC, da Silva MA, Mazzetto RG, Mazzetto MO. Low level laser effects on pain to palpation and electromyographic activity in TMD patients: a double-blind, randomized, placebo-controlled study. Cranio. 2010 Apr. 28(2):84-91. [View Abstract]
  25. Madani A, Ahrari F, Fallahrastegar A, Daghestani N. A randomized clinical trial comparing the efficacy of low-level laser therapy (LLLT) and laser acupuncture therapy (LAT) in patients with temporomandibular disorders. Lasers Med Sci. 2020 Feb. 35 (1):181-192. [View Abstract]
  26. Del Vecchio A, Floravanti M, Boccassini A, Gaimari G, Vestri A, Di Paolo C, et al. Evaluation of the efficacy of a new low-level laser therapy home protocol in the treatment of temporomandibular joint disorder-related pain: A randomized, double-blind, placebo-controlled clinical trial. Cranio. 2021 Mar. 39 (2):141-150. [View Abstract]
  27. Dib-Zakkour J, Flores-Fraile J, Montero-Martin J, Dib-Zakkour S, Dib-Zaitun I. Evaluation of the Effectiveness of Dry Needling in the Treatment of Myogenous Temporomandibular Joint Disorders. Medicina (Kaunas). 2022 Feb 9. 58 (2):[View Abstract]
  28. Di Francesco F, Minervini G, Siurkel Y, Cicciù M, Lanza A. Efficacy of acupuncture and laser acupuncture in temporomandibular disorders: a systematic review and meta-analysis of randomized controlled trials. BMC Oral Health. 2024 Feb 3. 24 (1):174. [View Abstract]
  29. Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: A systematic review. Clin Exp Dent Res. 2020 Feb. 6 (1):134-146. [View Abstract]
  30. Ramos-Herrada RM, Arriola-Guillén LE, Atoche-Socola KJ, Bellini-Pereira SA, Castillo AA. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review. Dent Med Probl. 2022 Apr-Jun. 59 (2):271-280. [View Abstract]
  31. Reeve GS, Insel O, Thomas C, Houle AN, Miloro M. Does the Use of Botulinum Toxin in Treatment of Myofascial Pain Disorder of the Masseters and Temporalis Muscles Reduce Pain, Improve Function, or Enhance Quality of Life?. J Oral Maxillofac Surg. 2023 Dec 28. 11 (7):1251-1263. [View Abstract]
  32. [Guideline] Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2022 Apr. 74 (4):553-569. [View Abstract]
  33. Surgical Management of TMJ Disorders. American Society of Temporomandibular Joint Surgeons. Available at https://astmjs.org/surgical-management-of-tmj-disorders-2/. Accessed: March 19, 2024.
  34. Silva PA, Lopes MT, Freire FS. A prospective study of 138 arthroscopies of the temporomandibular joint. Braz J Otorhinolaryngol. 2015 Jul-Aug. 81 (4):352-7. [View Abstract]
  35. Briceño F, Ayala R, Delgado K, Piñango S. Evaluation of temporomandibular joint total replacement with alloplastic prosthesis: observational study of 27 patients. Craniomaxillofac Trauma Reconstr. 2013 Sep. 6 (3):171-8. [View Abstract]
  36. Felix VB, Cabral DR, de Almeida AB, Soares ED, de Moraes Fernandes KJ. Ankylosis of the Temporomandibular Joint and Reconstruction With a Costochondral Graft in a Patient With Juvenile Idiopathic Arthritis. J Craniofac Surg. 2017 Jan. 28 (1):203-206. [View Abstract]
  37. Fricton JR, Look JO, Schiffman E, Swift J. Long-term study of temporomandibular joint surgery with alloplastic implants compared with nonimplant surgery and nonsurgical rehabilitation for painful temporomandibular joint disc displacement. J Oral Maxillofac Surg. 2002 Dec. 60(12):1400-11; discussion 1411-2. [View Abstract]
  38. Handa S, Shafik AA, Intini R, Keith DA. FIRST BITE SYNDROME - An Underrecognized and Underdiagnosed Pain Complication After Temporomandibular Joint Surgery. J Oral Maxillofac Surg. 2021 Oct 29. [View Abstract]